Skip to main content

Table 1 Characteristics of the T2DM patients by HDL cholesterol tertiles

From: Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study

 Lower tertile
< 41.5 mg/dL F
< 37.5 mg/dL M
Middle tertile
41.5 ≤ and < 52 mg/dL F
37.5 ≤ and < 47.5 mg/dL M
Higher tertile
≥52 mg/dL F
≥47.5 mg/dL M
P
Number700699714 
Males (%)45.345.243.70.79
Age (years)64.6 ± 11.865.8 ± 10.467.6 ± 10.1< 0.001
Age of DM diagnosis55.8 ± 12.555.4 ± 10.756.1 ± 10.70.57
Smoking (%)16.715.612.90.12
Treated with insulin (%)31.423.927.00.007
Treated with sulfonylureas (%)64.469.467.90.13
Treated with metformin (%)69.065.872.30.032
Treated with statins (%)3.06.99.0<0.001
Treated with fibrates (%)8.44.02.1< 0.001
Treated with hypotensive drugs (%)52.053.451.10.70
Treated with ACE-inhibitors33.633.629.70.19
Treated with acetylsalicylic acid (%)33.432.929.00.15
BMI (kg/m2)29.4 ± 5.529.2 ± 5.127.6 ± 4.7< 0.001
Systolic blood pressure (mmHg)143.2 ± 11.4143.6 ± 11.3144.3 ± 11.10.21
Diastolic blood pressure (mmHg)83.4 ± 4.583.0 ± 4.283.2 ± 4.50.23
HbA1c (%)6.7 ± 1.56.6 ± 1.26.5 ± 1.20.12
C-peptide (ng/mL) *2.3 ± 1.42.0 ± 1.21.8 ± 1.1< 0.001
Total cholesterol (mg/dL)198.2 ± 47.0209.1 ± 39.5213.4 ± 40.0< 0.001
Triglycerides (mg/dL) *177.6 ± 118.2139.7 ± 75.2106.3 ± 56.8< 0.001
Uric acid (mg/dL)5.5 ± 1.75.3 ± 1.55.0 ± 1.4< 0.001
Creatinine clearance (mL/min)107.1 ± 48.3106.9 ± 42.6105.8 ± 40.00.83
Retinopathy (%)20.920.921.90.87
Nephropathy (%)22.722.021.40.84
Neuropathy (%)9.69.38.50.78
Coronary artery diseases (%)21.320.016.50.06
Peripheral vascular diseases (%)18.117.016.10.59
Metabolic syndrome (%)64.145.633.5< 0.001
  1. *Kruskal–Wallis test
\